Literature DB >> 9619121

Antimicrobial activity of magnolol and honokiol against periodontopathic microorganisms.

B Chang, Y Lee, Y Ku, K Bae, C Chung.   

Abstract

Magnolol (1) and honokiol (2), main compounds from the stem bark of Magnolia obovata Thunb., were evaluated for an antimicrobial activity against periodontopathic microorganisms, Porphyromonas gingivalis, Prevotella gingivalis, Actinobacillus actinomycetemcomitans, Capnocytophaga gingivalis, and Veillonella disper, and a cytotoxicity against human gingival fibroblasts and epithelial cells. Our results indicate that magnolol and honokiol, although less potent than chlorhexidine, show a significant antimicrobial activity against these microorganisms, and a relatively low cytotoxic effect on human gingival cells. Thus, it is suggested that magnolol and honokiol may have a potential therapeutic use as a safe oral antiseptic for the prevention and the treatment of periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619121     DOI: 10.1055/s-2006-957453

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  11 in total

Review 1.  Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents.

Authors:  Mélanie Poivre; Pierre Duez
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

Review 2.  Honokiol, a multifunctional antiangiogenic and antitumor agent.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

3.  Antiprotozoal activity of medicinal plants against Ichthyophthirius multifiliis in goldfish (Carassius auratus).

Authors:  Yang-Lei Yi; Cheng Lu; Xue-Gang Hu; Fei Ling; Gao-Xue Wang
Journal:  Parasitol Res       Date:  2012-08-05       Impact factor: 2.289

4.  In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Guo-Ying Zuo; Xin-Juan Zhang; Jun Han; Yu-Qing Li; Gen-Chun Wang
Journal:  BMC Complement Altern Med       Date:  2015-12-01       Impact factor: 3.659

5.  In vitro inhibitory activities of magnolol against Candida spp.

Authors:  Peiru Zhou; Jingya Fu; Hong Hua; Xiaosong Liu
Journal:  Drug Des Devel Ther       Date:  2017-09-06       Impact factor: 4.162

6.  Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.

Authors:  Kao-Jean Huang; Chin-Ho Kuo; Shu-Hsin Chen; Ching-Yen Lin; Ying-Ray Lee
Journal:  J Cell Mol Med       Date:  2018-01-24       Impact factor: 5.310

7.  Magnolol ameliorates ligature-induced periodontitis in rats and osteoclastogenesis: in vivo and in vitro study.

Authors:  Sheng-Hua Lu; Ren-Yeong Huang; Tz-Chong Chou
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-21       Impact factor: 2.629

Review 8.  Neuro-modulating effects of honokiol: a review.

Authors:  Anna Woodbury; Shan Ping Yu; Ling Wei; Paul García
Journal:  Front Neurol       Date:  2013-09-11       Impact factor: 4.003

9.  Ophiobolin-O reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human breast carcinoma (MCF-7/ADR) cells.

Authors:  Wenxia Sun; Cuiting Lv; Tonghan Zhu; Xue Yang; Shanjian Wei; Jieyin Sun; Kui Hong; Weiming Zhu; Caiguo Huang
Journal:  Mar Drugs       Date:  2013-11-14       Impact factor: 5.118

10.  Efficacy of horse chestnut leaf extract ALH-L1005 as a matrix metalloproteinase inhibitor in ligature-induced periodontitis in canine model.

Authors:  Se Eun Kim; Tae Hyun Kim; Shin Ae Park; Won Tae Kim; Young Woo Park; Jae Sang Ahn; Manbok Jeong; Min-Young Kim; Kangmoon Seo
Journal:  J Vet Sci       Date:  2017-06-30       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.